Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features
- PMID: 26063644
- DOI: 10.1007/s12094-015-1303-1
Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features
Erratum in
-
Erratum to: Expression of serum miR-200a, miR-200b and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.Clin Transl Oncol. 2015 Oct;17(10):840. doi: 10.1007/s12094-015-1355-2. Clin Transl Oncol. 2015. PMID: 26243394 No abstract available.
Abstract
Background: MicroRNAs (miRs) have been implicated in the etiology of various human cancers. The aim of this study was to investigate the association of the expression of three members--miR 200a, miR 200b, and miR 200c belonging to the miR-200 family with clinicopathological characteristics and their impact on the progression of epithelial ovarian cancer (EOC).
Materials and methods: Total RNA from serum was isolated by Trizol method, polyadenylated, and reverse transcribed into cDNA. Expression levels of miR-200a, miR-200b, and miR-200c were detected by using miRNA qRT-PCR. We measured miR expression in 70 serum samples of EOC patients with matched controls using U6 snRNA as a reference. Levels of miR expression was compared with distinct clinicopathological features.
Results: Expression of miR-200a was found to be greater than six-fold (p = 0.01), miR-200b and miR-200c greater than three-fold (p = 0.01) in comparison with matched normal controls. Association of miRNA expression with clinicopathological factors and progression was statistically evaluated. The expression levels of miR-200a and miR-200c were found to be significantly associated with disease progression (p = 0.04 and p < 0.001, respectively). miR-200a overexpression was found be associated with tumor histology and stage. Patients with lymph node metastasis showed significant elevation of miR-200c (p = 0.006). The AUC in ROC curve also indicated that serum levels of miR-200a and miR-200c might be worthwhile as a diagnostic tool in the near future.
Conclusion: Our findings suggest that miR-200a, miR-200b, and miR-200c overexpressions are associated with the aggressive tumor progression and be recognized as reliable markers to predict the prognosis and survival in EOC patients.
Keywords: Biomarker; Disease progression; Overexpression; qRT-PCR.
Similar articles
-
Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.Oncotarget. 2016 Mar 29;7(13):16923-35. doi: 10.18632/oncotarget.7850. Oncotarget. 2016. PMID: 26943577 Free PMC article.
-
Clinicopathological and prognostic implications of the miR-200 family in patients with epithelial ovarian cancer.Int J Clin Exp Pathol. 2014 Apr 15;7(5):2392-401. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 24966949 Free PMC article.
-
The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer.Tumour Biol. 2016 Aug;37(8):11259-66. doi: 10.1007/s13277-016-4993-2. Epub 2016 Mar 7. Tumour Biol. 2016. PMID: 26951510
-
miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations.Oncotarget. 2016 Dec 6;7(49):81621-81633. doi: 10.18632/oncotarget.13154. Oncotarget. 2016. PMID: 27835595 Free PMC article. Review.
-
Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.Gene. 2019 Oct 20;716:144025. doi: 10.1016/j.gene.2019.144025. Epub 2019 Aug 5. Gene. 2019. PMID: 31394177 Review.
Cited by
-
Liquid Biopsy in the Clinical Management of High-Grade Serous Epithelial Ovarian Cancer-Current Use and Future Opportunities.Cancers (Basel). 2021 May 14;13(10):2386. doi: 10.3390/cancers13102386. Cancers (Basel). 2021. PMID: 34069200 Free PMC article. Review.
-
Transcriptomic analysis of patient plasma reveals circulating miR200c as a potential biomarker for high-grade serous ovarian cancer.Gynecol Oncol Rep. 2021 Dec 2;39:100894. doi: 10.1016/j.gore.2021.100894. eCollection 2022 Feb. Gynecol Oncol Rep. 2021. PMID: 35005155 Free PMC article.
-
Hsa_circ_0007534 as a blood-based marker for the diagnosis of colorectal cancer and its prognostic value.Int J Clin Exp Pathol. 2018 Mar 1;11(3):1399-1406. eCollection 2018. Int J Clin Exp Pathol. 2018. PMID: 31938236 Free PMC article.
-
In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.PLoS One. 2021 Apr 26;16(4):e0250717. doi: 10.1371/journal.pone.0250717. eCollection 2021. PLoS One. 2021. PMID: 33901236 Free PMC article.
-
The clinical impact of intra- and extracellular miRNAs in ovarian cancer.Cancer Sci. 2020 Oct;111(10):3435-3444. doi: 10.1111/cas.14599. Epub 2020 Aug 27. Cancer Sci. 2020. PMID: 32750177 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical